Valuation: Repligen Corporation

Market Cap 775.1Cr 677.98Cr 625.23Cr 578Cr 1.1TCr 74TCr 1.12TCr 7.48TCr 2.93TCr 36TCr 2.91TCr 2.85TCr 1,25800Cr P/E 2026 *
126x
P/E 2027 * 76.5x
Enterprise Value 749.66Cr 655.73Cr 604.7Cr 559.02Cr 1.06TCr 72TCr 1.08TCr 7.23TCr 2.84TCr 35TCr 2.81TCr 2.75TCr 1,21700Cr EV / Sales 2026 *
9.16x
EV / Sales 2027 * 7.76x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day+4.75%
1 week+3.56%
Current month+5.50%
1 month+14.85%
3 months+20.18%
6 months-13.51%
Current year-12.16%
1 week 135.08
Extreme 135.08
144.58
1 month 124.85
Extreme 124.85
149.05
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 25.93
Extreme 25.93
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
25/06Sell

Chief Financial Officer

-733 0.0013%
14/05Free

Director

3,234 0.0057%
14/05Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+4.75%+3.56%+11.96%+1.70% 775.1Cr
-0.82%+2.41%-29.21%-11.24% 17TCr
+0.46%+4.03%-6.99%-4.07% 10TCr
-2.30%+4.87%+1.49%+58.47% 6.02TCr
+3.64%-4.34%+45.42%+51.88% 4.92TCr
+0.19%-1.34%-13.62%-41.29% 4.15TCr
+1.36%-2.11% - - 3.41TCr
-1.40%+6.04%-12.82%-42.37% 2.86TCr
+1.13%-2.01%+62.22%-3.75% 2.5TCr
-2.15%+3.29%-9.38%+3.10% 2.06TCr
Average +0.42%+1.65%+5.45%+1.38% 5.38TCr
Weighted average by Cap. -0.15%+2.12%-5.42%+1.67%

Financials

2026 *2027 *
Net sales 82Cr 72Cr 66Cr 61Cr 115.94Cr 7.8TCr 117.88Cr 789.63Cr 309.58Cr 3.84TCr 307.17Cr 300.52Cr 13TCr 94Cr 83Cr 76Cr 70Cr 133.67Cr 9TCr 135.9Cr 910.32Cr 356.89Cr 4.43TCr 354.12Cr 346.45Cr 15TCr
Net income 6.11Cr 5.34Cr 4.93Cr 4.56Cr 8.66Cr 582.67Cr 8.8Cr 59Cr 23Cr 286.7Cr 23Cr 22Cr 991.87Cr 10Cr 8.85Cr 8.16Cr 7.54Cr 14Cr 964.98Cr 15Cr 98Cr 38Cr 474.82Cr 38Cr 37Cr 1.64TCr
Net Debt -25Cr -22Cr -21Cr -19Cr -36Cr -2.43TCr -37Cr -245.54Cr -96Cr -1.19TCr -96Cr -93Cr -4.13TCr -43Cr -38Cr -35Cr -32Cr -61Cr -4.12TCr -62Cr -416.77Cr -163.4Cr -2.03TCr -162.13Cr -158.62Cr -7.01TCr
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
09/26/09 $143.94 +4.75% 6,67,100
08/26/08 $137.41 -1.73% 6,89,024
07/26/07 $139.83 -1.15% 6,17,789
06/26/06 $141.46 -0.66% 6,66,683
02/26/02 $142.40 +2.45% 9,85,760
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
143.94USD
Average target price
177.05USD
Spread / Average Target
+23.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock